Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALS.

Rutherford BR, Bailey VS, Schneier FR, Pott E, Brown PJ, Roose SP.

Depress Anxiety. 2015 Dec;32(12):944-57. doi: 10.1002/da.22433. Epub 2015 Oct 5.

2.

Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition.

Perna G, Daccò S, Menotti R, Caldirola D.

Neuropsychiatr Dis Treat. 2011;7:621-37. doi: 10.2147/NDT.S12979. Epub 2011 Oct 19.

3.

Pregabalin influences insula and amygdala activation during anticipation of emotional images.

Aupperle RL, Ravindran L, Tankersley D, Flagan T, Stein NR, Simmons AN, Stein MB, Paulus MP.

Neuropsychopharmacology. 2011 Jun;36(7):1466-77. doi: 10.1038/npp.2011.32. Epub 2011 Mar 23.

4.

Possible cross-sensitivity between sertraline and paroxetine in a panic disorder patient.

Khairkar PH, Bang GM, Singh AB, Tiple PG.

Indian J Pharmacol. 2010 Apr;42(2):110-1. doi: 10.4103/0253-7613.64497.

5.

Pharmacotherapy of panic disorder.

Pull CB, Damsa C.

Neuropsychiatr Dis Treat. 2008 Aug;4(4):779-95.

6.

Escitalopram in adolescent major depression.

Schaller JL, Rawlings DB.

MedGenMed. 2005 Jan 31;7(1):6.

Supplemental Content

Support Center